Curio Wealth LLC Invests $67,000 in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Curio Wealth LLC acquired a new position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 748 shares of the exchange traded fund’s stock, valued at approximately $67,000.

A number of other hedge funds also recently made changes to their positions in the stock. Healthcare of Ontario Pension Plan Trust Fund raised its position in SPDR S&P Biotech ETF by 198.6% in the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 9,229,000 shares of the exchange traded fund’s stock worth $911,825,000 after purchasing an additional 6,138,000 shares during the period. Clal Insurance Enterprises Holdings Ltd purchased a new position in SPDR S&P Biotech ETF during the third quarter valued at $141,284,000. Proficio Capital Partners LLC increased its holdings in shares of SPDR S&P Biotech ETF by 16,156.1% in the 4th quarter. Proficio Capital Partners LLC now owns 917,329 shares of the exchange traded fund’s stock worth $82,615,000 after purchasing an additional 911,686 shares in the last quarter. Raymond James Financial Inc. bought a new stake in shares of SPDR S&P Biotech ETF in the 4th quarter worth $55,529,000. Finally, J.Safra Asset Management Corp increased its holdings in shares of SPDR S&P Biotech ETF by 461.6% in the 4th quarter. J.Safra Asset Management Corp now owns 292,502 shares of the exchange traded fund’s stock worth $26,293,000 after purchasing an additional 240,415 shares in the last quarter.

SPDR S&P Biotech ETF Trading Up 1.3 %

SPDR S&P Biotech ETF stock opened at $87.13 on Monday. The firm has a market cap of $5.65 billion, a price-to-earnings ratio of 11.47 and a beta of 0.99. The stock has a fifty day simple moving average of $90.06 and a two-hundred day simple moving average of $94.78. SPDR S&P Biotech ETF has a 12 month low of $81.14 and a 12 month high of $105.47.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.